ACTA1 and idiopathic pulmonary fibrosis: Interestingly, the addition of pirfenidone with AXP2258 to cultures of slow and rapid IPF fibroblasts significantly inhibited α-SMA protein expression in these cells compared with pirfenidone treatment alone.